Healthcare OTC Product Shopper Trends - Insights into The COVID Effect

Thank you

This live web event has ended. Thank you for attending.

Description

While COVID-19 has had a profound effect on the healthcare industry in general, it has had a unique impact on shopper purchase dynamics of over-the-counter (OTC) product categories. During this panel discussion, attendees will discover how consumer behaviors have changed and varied by OTC category because of COVID-19. We will share what we've observed and insights we've gleaned from the pandemic's initial months, during the subsequent year, as well as current and emerging shopper trends at the time of the webinar. We will identify marketing opportunities to seize and potential strategies for OTC brands to pursue as well as address some of the ongoing challenges from the pandemic that brands can expect to face.

Webinar Objectives

Put in context the effect COVID-19 has had on shopper behavior across OTC product categories. What did we learn and how can marketers best prepare for what's ahead?
Convey current and emerging OTC shopper trends as vaccination rates increase, mask-wearing declines, and workplace mandates become more commonplace.
Examine viable OTC brand marketing opportunities and strategies based on Catalina shopper insights from 85 million households and 700 audience segments across the U.S.

Presented by Founding Education Partner

Contributors

Paul Flugel, SVP – Marketing Performance & Brand Analytics at Catalina

Paul Flugel leads Catalina’s Marketing Performance & Brand Analytics team, engaging with client analytic leaders and 3^rd-party measurement firms to ensure marketing measurement is accurate, in context, and connected to business objectives.
Previously, Paul was the analytic lead on the team that developed and launched the industry’s first Customer & Prospect Relationship Management (CPRM) platform. He also led Nielsen’s North American Marketing ROI Practice and IRI’s Analytic Consulting Group in Chicago. Paul earned a bachelor’s degree in physics from Cornell University and an MBA from Loyola University Chicago’s Quinlan School of Business.
Brian Maki, SVP – US Direct Sales at Catalina

Brian Maki is SVP of US Direct Sales at Catalina. He is responsible for leading and overseeing all aspects of Catalina’s CPG and Agency go-to-market team. They leverage the CPG industry’s most robust shopper dataset to consult with brands and agencies on shopper insights, omnichannel activation, and measurement and data services solutions.
Prior to Catalina, Brian led a team in IRI’s Client Services organization. Brian earned a bachelor’s degree in Economics from Northern Illinois University and an MBA from Lewis University.
Richard Qian, Brand Lead at Sanofi Consumer Healthcare

Richard Qian is a results-driven brand leader in consumer healthcare currently leading Xyzal and Nasacort, two allergy brands at Sanofi Consumer Healthcare. He leads brand strategy, advertising, promotions, and P&L and have launched new brand campaigns right before COVID-19 break.
Richard has over a decade experience across consumer health brand management, private equity, investment banking, and MBA from Harvard Business School.

Thank you

Description

Contributors

Paul Flugel, SVP – Marketing Performance & Brand Analytics at Catalina

Brian Maki, SVP – US Direct Sales at Catalina

Richard Qian, Brand Lead at Sanofi Consumer Healthcare